Management of Hepatitis C-Infected Patients After Sustained Virological Response
- PMID: 32714519
- PMCID: PMC7373773
- DOI: 10.1002/cld.913
Management of Hepatitis C-Infected Patients After Sustained Virological Response
Abstract
Watch an interview with the author Answer questions and earn CME.
© 2020 by the American Association for the Study of Liver Diseases.
Figures
References
-
- Carat F, Helene F, Dorival C, et al. Clinical outcomes in patients with chronic hepatitis C after direct‐acting antiviral treatment: A prospective cohort study. Lancet 2019;393:1453‐1464. - PubMed
-
- Bruno S, Di Marco V, Iavorone M, et al. Survival of patients with HCV cirrhosis and sustained virologic response is similar to the general population. J Hepatol 2016;64:1217‐1223. - PubMed
-
- American Association for the Study of Liver Diseases and Infectious Diseases Society of America . Recommendations for testing, management and treating hepatitis C. Available at: http://www.hcvguidelines.org/. Accessed July 15, 2019. - PMC - PubMed
-
- Schwabe C, Lawitz EJ, Pol S, et al. Sustained viral response following treatment with direct acting antiviral regimens is durable in more than 6,600 patients: results of the Gilead sustained virologic response registry study Proceedings of the American Association for the Study of Liver Diseases. San Francisco: Wiley; 2019:595 abs.
-
- Aspinall EJ, Corson S, Doyle JS, et al. Treatment of hepatitis C virus infection among people who are actively injecting drugs: A systematic review and meta‐analysis. Clin Infect Dis 2013;57(suppl 2):580‐589. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
